Immunological Data Discovery Index
Advanced Search
identifier: 1866660
description:
epitope description:S17, I21, Q25, H27, V29, E31, Y32, D33, P34, T35, I36, E37, D38, S39, Y40, Q61, E63, Y64
antigen name:GTPase HRas
host organism:Homo sapiens
antibody name:anti-RAS
aggregation:
instance of dataset
availability:
available
primaryPublications: 17568777
authorizations:
registration not required
accessURL: http://www.iedb.org/reference/1018825
landingPage: http://www.iedb.org/assay/1866660
type:
Literature
publicationVenue:
EMBO J
dates:
2007
study type: b cell assays
subject species: Homo sapiens
fullName:
Tomoyuki Tanaka
Roger L Williams
Terence H Rabbitts
method:
surface plasmon resonance (SPR)
name:
Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RAS.
description:
Epitope residues are calculated from the structure [PDB: 2UZI] as the antigen residues at 4 Å
distance from the antibody.
The epitope-specific anti-RAS scFv#6 intrabody bound to activated HRAS-GTP(gammaS) with high affinity. The single VH#6 domain (iDab#6) without the VL domain had an affinity of KD = 6.2 nM (k on = 2.93 x 105 and k off = 1.82 x 10-3). Anti-RAS does not bind to HRAS-GDP. The single VH#6 domain (iDab#6) bound to oncogenic HRAS with mutations at either residue 12 or 61 with higher affinity than to wt HRAS. The intrabody iDab#6 did not bind to RAS with mutations at residues 10, 15, 17 or 57, and mutations at residues 33, 35, 38, 40, or 64 reduced binding.

Feedback?

If you are having problems using our tools, or if you would just like to send us some feedback, please post your questions on Feedback.